Compass Therapeutics, Inc. · NASDAQ:CMPX
Compass Therapeutics, Inc. shareholders
As of Sep 30, 2026, 169 institutions reported holding Compass Therapeutics, Inc., 89.2% of its shares. Largest: Tang Capital Management LLC, Orbimed Advisors LLC and Montanova Capital, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Compass Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Tang Capital Management LLC | 18M | 10.0% | no change | Nov 16, 2026 |
| Orbimed Advisors LLC | 15.2M | 8.5% | no change | Nov 16, 2026 |
| Montanova Capital, LLC | 14.3M | 8.0% | +226K | Nov 16, 2026 |
| BlackRock | 11.4M | 6.3% | +113K | Nov 13, 2026 |
| Vanguard | 9.11M | 5.1% | −1.84M | Nov 13, 2026 |
| Enavate Sciences Gp, LLC | 7.79M | 4.3% | no change | Nov 16, 2026 |
| State Street | 7.74M | 4.3% | −2.22M | Nov 12, 2026 |
| Palo Alto Investors LP | 7.15M | 4.0% | +1.32M | Nov 16, 2026 |
| Millennium | 4.69M | 2.6% | −26,825 | Nov 16, 2026 |
| Qube Research & Technologies Ltd | 4.17M | 2.3% | +483K | Nov 13, 2026 |